SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mr. Moose who wrote (406)3/11/1997 7:09:00 PM
From: Peter Church   of 6136
 
You should see those Marigolds and the Apple blossoms! It's 70F here and beautiful outside! I've been walking alot.

I heard some well placed scoobie-doo that questions were sent from the FDA to Agouron regarding their data. The questions were thought to be answered by the company and we're all awaiting approval "Any day". The $1 billion question: WHEN??

Hard to say how low we can go until some good news makes the scene. We're sort of adrift here, I think.

The news from the AIDS network is that Viracept is well tolerated and recommended especially for first time patients. There is still a cross resistance debate, but it's too early to tell. The drug is well tolerated. Nothing new on the clinical front and that's good! Merck is negative about the Viracept results, but they got a lot to loose.

Could it be that Merck is pulling ropes to keep the FDA moving at a snail's pace? Just paranoid speculation.

Best regards---Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext